Latest report on Tardive Dyskinesia Market of 51 pages now added by a leading business intelligence provider to MarketReportsOnline.com database.
Pune, India -- (SBWIRE) -- 07/03/2017 -- Tardive dyskinesia is an involuntary movement disorder that typically arises from the long-term use of antipsychotic medication in schizoaffective disorders. Tardive dyskinesia is characterized by involuntary, repetitive movements of the face, trunk, or extremities, including lip smacking, grimacing, tongue protrusion, facial movements or blinking, puckering and pursing of the lips.
Complete report on Tardive Dyskinesia market spread across 51 pages with providing 3 company profiles and 24 charts is now available at http://www.marketreportsonline.com/600361.html.
TDs are most common in patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have been treated with antipsychotic medication for long periods, but they occasionally occur in other patients as well.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
Purchase a copy of this "Tardive Dyskinesia Market Report: Focus on US & Japan -2025" research report at USD 600 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=600361.
The report "Tardive Dyskinesia Market" provides a comprehensive study of the US and Japan tardive dyskinesia market with detailed analysis of market size, growth and penetration of the industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this tardive dyskinesia market report. The industry comprises few large players such as Valeant Pharmaceuticals, Neurocrine Biosciences and Teva Pharmaceuticals Industries Ltd. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.
Major Points from Table of Contents:
1. Tardive Dyskinesias - An Overview
1.1 Antipsychotics Overview
1.2 Tardive Dyskinesias
1.3 Signs and Symptoms
1.6 Existing and Pipeline Drugs
2. The US Tardive Dyskinesia Market Analysis
2.1 The US Tardive Dyskinesia Market by Number of Patients
2.2 The US Tardive Dyskinesia - Number of Patients by Severity
2.3 The US Tardive Dyskinesia Sales by Value
2.4 The US Tardive Dyskinesia Annual Price
3. Japan Tardive Dyskinesia Market Analysis
3.1 Japan Tardive Dyskinesia Market by Number of Patients
3.2 Japan Tardive Dyskinesia - Number of Patients by Severity
3.3 Japan Tardive Dyskinesia Sales by Value
3.4 Japan Tardive Dyskinesia Annual Price
4. The US Tardive Dyskinesia Drugs Market Analysis
4.1 The US Valbenazine Market by Penetration
4.2 The US SD-809 Market by Penetration
4.3 The US Tetrabenazine Market For Tardive Dyskinesia by Penetration
5. Market Dynamics
5.1 Growth Drivers
5.2 Market Trends
6. Competitive Landscape
6.1 Comparison between Valbenazine vs. SD-809
7. Company Profiles
Other Related Reports on Tardive Dyskinesia Market:
US Tardive Dyskinesia Market: Size, Trends & Forecasts (2016-2025): Psychosis is a condition described as loss of contact with reality. And the people suffering from this condition are called psychotics. Some of the signs and symptom of psychosis are: difficulty in concentrating, depressed mood, sleeping too much or not enough, anxiety, etc. The two main types of psychiatric disorder related to tardive dyskinesia are Schizophrenia and Bipolar Disorder. Complete report available at http://www.marketreportsonline.com/535595.html.
Tardive Dyskinesia-Pipeline Insights, 2017: This report provides in depth insights on the pipeline drugs and their development activities around the Tardive Dyskinesia. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Tardive Dyskinesia. Complete report available at http://www.marketreportsonline.com/565606.html.
Explore more related reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Tel: + 1 888 391 5441